Mirvie

San Francisco, California, United States
Purpose
To clinically verify Mirvie's cell-free RNA (cfRNA)-based classifier to predict the risk of a woman developing preterm preeclampsia (ptPE that necessitates a delivery <37 weeks)="" in="" an="" lmic="" population="" weeks)="" in="" an="" lmic="">
Grantee
Division
Gender Equality
Date
MARCH 2023
Region served
AFRICA
Committed amount
$4,705,126
Grant topic
Maternal, Newborn, Child Nutrition and Health
Duration (months)
37
Grantee location
San Francisco, California, United States
Related work

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.